PRVCF 0.02 PreveCeutical Medical Inc.
| Range: | 0.01-0.0228 | Vol Avg: | 23544 | Last Div: | 0 | Changes: | 0 |
| Beta: | 0.94 | Cap: | 0.01B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Mon Aug 21 2017 | Empoloyees: | 7 | ||
| CUSIP: | CIK: | ISIN: | CA74141E1043 | Country: | CA | ||
| CEO: | Mr. Stephen Van Deventer | Website: | https://www.preveceutical.com | ||||
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.
Stock Details
Positive 0.57
PreveCeutical Engages Phoenix Corporate Finance Inc. to Provide Advisory Services
Vancouver, British Columbia--(Newsfile Corp. - October 18, 2024) - PreveCeutical Medical I...
newsfilecorp.com·Fri Oct 18 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow